Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 6/20 | 0.33 |
| ▸ | CES1 | P23141 | 5/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5586198 | 0.91 | EPHX1 (0.46) | EPHX1FAAHCES1CES2SERPINE1 | |
| SCHEMBL5586239 | 0.91 | EPHX1 (0.46) | EPHX1FAAHCES1CES2SERPINE1 | |
| SCHEMBL19099806 | 0.91 | EPHX1 (0.46) | EPHX1FAAHCES1CES2SERPINE1 | |
| SCHEMBL2203447 | 0.91 | EPHX1 (0.46) | EPHX1FAAHCES1CES2SERPINE1 | |
| SCHEMBL12902479 | 0.86 | CA1 (0.46) | TDP1EPHX1CA1CA12CA2 | |
| SCHEMBL18574650 | 0.85 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL5593702 | 0.85 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL17509760 | 0.83 | CA1 (0.30) | EPHX1CA1CA2 | |
| SCHEMBL17865364 | 0.83 | CA1 (0.30) | EPHX1CA1CA2 | |
| SCHEMBL5586201 | 0.83 | CA1 (0.30) | EPHX1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007091817-A1 | ANION RECEPTOR, AND ELECTROLYTE USING THE SAME | KIM HEE JUNG (KR) | 2007-08-16 | — | — | WO | claimed |
| US-20250289781-A1 | TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-09-18 | — | — | US | disclosed |
| WO-2023214552-A1 | TRIFLUOROMETHANE SULFONYLATION AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANE SULFONYL COMPOUND | セントラル硝子株式会社 | 2023-11-09 | — | — | WO | disclosed |
| WO-2017112972-A1 | METHOD FOR PRODUCING IONIC LIQUIDS | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2017-07-06 | — | — | WO | disclosed |
| US-7799204-B2 | Voltammetric Ion Sensor | OXFORD BIOSENSORS LIMITED (GB) | 2010-09-21 | — | — | US | disclosed |
| WO-2007091817-A1 | ANION RECEPTOR, AND ELECTROLYTE USING THE SAME | KIM HEE JUNG (KR) | 2007-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289781-A1 | TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND | AFF1, BRAF, AFF2 | TDP1 1156/4885EPHX1 951/4885CA1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.